iamYiam Ltd.のプレスリリース
Scientific advice on life quality research from nutrition, metabolism and planetary health

London and Tokyo, 19 November 2026 — Syd Life AI (headquartered in London, United Kingdom; Founder and Group CEO: Lorena Puica) announces that Professor Shin-Ichiro Takahashi, Project Professor at the Research Institute of Planetary Health, The University of Tokyo, joined its International Scientific Advisory Committee on 1 November 2026.
Professor Takahashi serves on the Committee in his personal capacity as a scientist, not as a representative of the University. He will advise on the scientific direction of life quality assessment, its connections with nutrition and metabolism, and questions of research validity and ethics. His appointment does not constitute an endorsement or guarantee of Syd Life AI’s business, products or services by The University of Tokyo, nor does it imply an institutional partnership with the University.
Background
Syd Life AI develops technologies and services designed to help people understand and improve their life quality across multiple dimensions, including physical and emotional health, social connections, career, financial health, environment, brain power, self-awareness and purpose. Its approach draws on the Life Quality Index (LQI) and an AI-based Large Quantitative Model (LQM).
Professor Takahashi has conducted long-standing research on insulin and insulin-like growth factor (IGF) signalling and amino-acid regulation of metabolism, examining their connections with nutrition, growth, ageing and health. His recent work also explores AI- and digitally enabled personalised nutrition and food systems that support both human health and planetary sustainability.
Bringing health and life quality measures into practical use requires continued scrutiny of their scientific foundations, measurement validity, reproducibility across populations and research ethics. Syd Life AI welcomes Professor Takahashi’s academic perspective as it seeks to strengthen the quality of its research and technology development.
Areas of scientific advice
• Scientific validity, validation approaches and interpretability of assessment frameworks, including the Life Quality Index (LQI)
• Research directions connecting nutrition, metabolism and ageing with life quality
• Scientific advice on the transparency of evidence, research ethics and responsible use of AI
Comment from Lorena Puica, Founder and Group CEO of Syd Life AI
“Our aim is to understand life quality through science and translate that understanding into insights that can support everyday decisions. We are delighted to welcome Professor Takahashi, whose work spans the fundamental science of metabolic regulation and nutrition as well as the broader challenges of planetary health. We value his independent perspective and candid advice as we continue to emphasise the validity of our assessment methods, transparency and research ethics.”
Comment from Professor Shin-Ichiro Takahashi
“Human health and quality of life are shaped not only by nutrition and metabolism, but also by our living and social environments and the health of the planet. Understanding these relationships scientifically, and using that knowledge to support better choices tailored to individuals, is an important challenge for the future of health science. In my personal capacity as a scientist, I will offer candid and constructive advice, with particular attention to the validity and verifiability of assessment measures and to research ethics. I look forward to exploring how science can contribute to improving quality of life while advancing planetary health.”
Profile: Professor Shin-Ichiro Takahashi
Project Professor, Research Institute of Planetary Health, The University of Tokyo. PhD in Agriculture, The University of Tokyo. Previously Professor at the Graduate School of Agricultural and Life Sciences, The University of Tokyo. His research focuses on insulin and IGF signalling, amino-acid regulation of metabolism, and their relationships with nutrition, growth, ageing and health. He is also engaged in AI- and digitally enabled personalised nutrition, sustainable food design, and the One Earth Guardians education programme, which develops people able to address global challenges across disciplines.
About Syd Life AI
Syd Life AI provides infrastructure that measures and improves people’s life quality.* Headquartered in London, it works with governments, health systems and employers in 26 countries. In Japan, the business is run by Syd Life AI Japan K.K.
Life Quality Index (LQI): captures each person’s life quality through 2,390 indicators across nine dimensions: physical health, emotional health, social life, career, financial health, environment, brain power, self-awareness and purpose. In 2019 the World Intellectual Property Organization (WIPO) and Cornell University recognised the LQI as a “Gold Standard”.
Large Quantitative Model (LQM): Syd’s proprietary quantitative model for life quality, built on more than 2.7 million research papers and more than 14.3 billion person-years of longitudinal data (both as of May 2026). It makes recommendations tailored to each person and organisation, with the supporting research cited.
Research collaboration: Syd is working with researchers at the Massachusetts Institute of Technology (MIT), Stanford University, Cornell University, the University of Toronto and Seoul National University.
Recognition: in 2025, Syd received the Osaka Governor’s Award at the Global Healthcare Challenge (GHeC), held by JETRO and Japan’s Ministry of Economy, Trade and Industry during Expo 2025 Osaka, Kansai. Syd’s other recognition includes the 2025 Outstanding Virtual Health Delivery – Specialised Care award at the MENA Telehealth & Virtual Care Expo (2025), selection as a Future 100 company by the UAE Ministry of Economy (2024), selection by the UK Government as one of the UK’s First 100 Digital Health Companies, the European Commission’s Seal of Excellence (2020) and the Future of Health award from WIPO and Cornell University (2019).
Integrity at every step: Integrity, Authenticity and Purpose have been Syd’s values since its founding, and every recommendation is designed to be traceable to the research behind it. Syd holds SOC 2, ISO/IEC 27001 and ISO/IEC 42001 certification for information security and AI management, and complies with the EU General Data Protection Regulation (GDPR) and the US Health Insurance Portability and Accountability Act (HIPAA).
Company details and media contact
Company: iamYiam Limited (trading as Syd Life AI)
Headquarters: London, United Kingdom
Founder and Group CEO: Lorena Puica
Japan entity: Syd Life AI Japan K.K. (Minato-ku, Tokyo)
Website: https://syd.life/
Media contact: Syd Life AI Communications / syd@syd.life
Note
* Syd (the syd™ Super-App and the syd™ Population Analytics Dashboard) is designed to support people in improving their life quality, and is not a medical device. It is not intended to measure, diagnose, evaluate or treat disease. In Japan, a review by external legal counsel under the Act on Pharmaceuticals and Medical Devices (PMD Act) concluded that Syd does not qualify as a medical device program. In the United Kingdom, Syd is not a medical device under the guidance of the Medicines and Healthcare products Regulatory Agency (MHRA).

